• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小分子调节剂对ATP与骨骼肌兰尼碱受体结合的影响。

Effects of small molecule modulators on ATP binding to skeletal ryanodine receptor.

作者信息

Dias José M, Vogel Pia D

机构信息

Department of Biological Sciences, Southern Methodist University, 6501 Airline Rd, Dallas, TX 75275, USA.

出版信息

Protein J. 2009 Jun;28(5):240-6. doi: 10.1007/s10930-009-9189-9.

DOI:10.1007/s10930-009-9189-9
PMID:19636685
Abstract

Calcium release for muscle contraction in skeletal muscle is mediated in part by the ryanodine receptor 1, RyR1, Ca2+-channel and is strongly affected by intrinsic modulators like Ca2+, Mg2+ and ATP. We showed differential effects on ATP binding in the presence of Ca2+ or Mg2+ ions using ESR spectroscopy and a spin-labeled ATP analog, SL-ATP (Dias et al. Biochemistry 45: 9408-9415, 2006). We here report the effects of RyR1 modulators like ryanodine, caffeine and dantrolene on the ATP binding of RyR1 using the same technique. We present evidence that the exogenous effectors induce changes within RyR1 that lead to different ATP binding characteristics: In the presence of the activating modulator, caffeine, or in the presence of ryanodine, which causes a half-open state of the channel, binding of eight ATP per RyR1 was observed, even in the presence of inhibitory Ca2+, suggestive of a stable "open" channel conformation. In the presence of the inhibitory modulator dantrolene, ATP binding affinity decreased in the presence of activating Ca2+, while in the presence of inhibitory Ca2+, ATP binding affinity increased, but at the same time the number of accessible sites decreased to four, suggestive of a closed conformation of the channel. The results imply that modulation of ATP binding to RyR1 as well as the overall number of accessible ATP binding sites on the channel are crucial for regulation and are in direct correlation with the modified activity of the channel induced by pharmacological agents.

摘要

骨骼肌中肌肉收缩的钙释放部分由兰尼碱受体1(RyR1)钙通道介导,并受到Ca2+、Mg2+和ATP等内在调节剂的强烈影响。我们使用电子顺磁共振光谱和自旋标记的ATP类似物SL-ATP,展示了在Ca2+或Mg2+离子存在下对ATP结合的不同影响(迪亚斯等人,《生物化学》45: 9408 - 9415,2006年)。我们在此报告使用相同技术,兰尼碱、咖啡因和丹曲林等RyR1调节剂对RyR1的ATP结合的影响。我们提供的证据表明,外源性效应物会在RyR1内诱导变化,从而导致不同的ATP结合特性:在激活调节剂咖啡因存在下,或在导致通道半开放状态的兰尼碱存在下,即使在抑制性Ca2+存在的情况下,每个RyR1也观察到八个ATP的结合,这表明通道具有稳定的“开放”构象。在抑制性调节剂丹曲林存在下,在激活Ca2+存在时ATP结合亲和力降低,而在抑制性Ca2+存在时,ATP结合亲和力增加,但同时可及位点的数量减少到四个,这表明通道处于关闭构象。结果表明,ATP与RyR1结合的调节以及通道上可及ATP结合位点的总数对于调节至关重要,并且与药物诱导的通道活性改变直接相关。

相似文献

1
Effects of small molecule modulators on ATP binding to skeletal ryanodine receptor.小分子调节剂对ATP与骨骼肌兰尼碱受体结合的影响。
Protein J. 2009 Jun;28(5):240-6. doi: 10.1007/s10930-009-9189-9.
2
Structural and functional interactions between the Ca-, ATP-, and caffeine-binding sites of skeletal muscle ryanodine receptor (RyR1).骨骼肌兰尼碱受体(RyR1)的钙、ATP 和咖啡因结合位点之间的结构和功能相互作用。
J Biol Chem. 2021 Sep;297(3):101040. doi: 10.1016/j.jbc.2021.101040. Epub 2021 Aug 2.
3
Halothane modulation of skeletal muscle ryanodine receptors: dependence on Ca2+, Mg2+, and ATP.氟烷对骨骼肌兰尼碱受体的调节作用:对Ca2+、Mg2+和ATP的依赖性
Am J Physiol Cell Physiol. 2008 Apr;294(4):C1103-12. doi: 10.1152/ajpcell.90642.2007. Epub 2008 Feb 27.
4
Mutations to Gly2370, Gly2373 or Gly2375 in malignant hyperthermia domain 2 decrease caffeine and cresol sensitivity of the rabbit skeletal-muscle Ca2+-release channel (ryanodine receptor isoform 1).恶性高热结构域2中Gly2370、Gly2373或Gly2375的突变会降低兔骨骼肌Ca2+释放通道(兰尼碱受体同工型1)对咖啡因和甲酚的敏感性。
Biochem J. 2001 Nov 15;360(Pt 1):97-105. doi: 10.1042/0264-6021:3600097.
5
Characterization of recombinant rabbit cardiac and skeletal muscle Ca2+ release channels (ryanodine receptors) with a novel [3H]ryanodine binding assay.利用新型[3H]ryanodine结合试验对重组兔心肌和骨骼肌Ca2+释放通道(兰尼碱受体)进行表征。
J Biol Chem. 1998 Dec 11;273(50):33259-66. doi: 10.1074/jbc.273.50.33259.
6
A central core disease mutation in the Ca-binding site of skeletal muscle ryanodine receptor impairs single-channel regulation.骨骼肌兰尼碱受体钙结合位点的核心疾病突变会损害单通道调节。
Am J Physiol Cell Physiol. 2019 Aug 1;317(2):C358-C365. doi: 10.1152/ajpcell.00052.2019. Epub 2019 Jun 5.
7
Differential activation by Ca2+, ATP and caffeine of cardiac and skeletal muscle ryanodine receptors after block by Mg2+.镁离子阻断后钙离子、三磷酸腺苷和咖啡因对心肌和骨骼肌兰尼碱受体的差异激活作用。
J Membr Biol. 2002 May 1;187(1):51-64. doi: 10.1007/s00232-001-0150-x.
8
Dantrolene inhibition of ryanodine receptor Ca2+ release channels. Molecular mechanism and isoform selectivity.丹曲林对兰尼碱受体Ca2+释放通道的抑制作用。分子机制及亚型选择性。
J Biol Chem. 2001 Apr 27;276(17):13810-6. doi: 10.1074/jbc.M006104200. Epub 2001 Feb 5.
9
Coupled gating of skeletal muscle ryanodine receptors is modulated by Ca2+, Mg2+, and ATP.钙离子、镁离子和 ATP 调节骨骼肌兰尼碱受体的偶联门控。
Am J Physiol Cell Physiol. 2012 Sep 15;303(6):C682-97. doi: 10.1152/ajpcell.00150.2012. Epub 2012 Jul 11.
10
Ca-mediated activation of the skeletal-muscle ryanodine receptor ion channel.钙介导的骨骼肌兰尼碱受体离子通道的激活。
J Biol Chem. 2018 Dec 14;293(50):19501-19509. doi: 10.1074/jbc.RA118.004453. Epub 2018 Oct 19.

引用本文的文献

1
Allosteric modulation of ryanodine receptor RyR1 by nucleotide derivatives.核苷酸衍生物对兰尼碱受体 RyR1 的变构调节。
Structure. 2023 Jul 6;31(7):790-800.e4. doi: 10.1016/j.str.2023.04.009. Epub 2023 May 15.
2
The Ryanodine Receptor as a Sensor for Intracellular Environments in Muscles.肌质网 Ryan 受体作为细胞内环境的传感器。
Int J Mol Sci. 2021 Oct 6;22(19):10795. doi: 10.3390/ijms221910795.
3
Review of RyR1 pathway and associated pathomechanisms.RyR1 通路及相关发病机制的研究进展。

本文引用的文献

1
Insights into the regulation of the ryanodine receptor: differential effects of Mg2+ and Ca2+ on ATP binding.对兰尼碱受体调控的见解:Mg2+和Ca2+对ATP结合的不同影响。
Biochemistry. 2006 Aug 8;45(31):9408-15. doi: 10.1021/bi060623a.
2
Nucleotide binding to the multidrug resistance P-glycoprotein as studied by ESR spectroscopy.通过电子自旋共振光谱研究核苷酸与多药耐药性P-糖蛋白的结合。
Biochemistry. 2005 Oct 25;44(42):14010-9. doi: 10.1021/bi0512445.
3
Some precautions in using chelators to buffer metals in biological solutions.在生物溶液中使用螯合剂缓冲金属时的一些注意事项。
Acta Neuropathol Commun. 2016 Nov 17;4(1):121. doi: 10.1186/s40478-016-0392-6.
4
Structural Basis for Gating and Activation of RyR1.兰尼碱受体1(RyR1)门控与激活的结构基础
Cell. 2016 Sep 22;167(1):145-157.e17. doi: 10.1016/j.cell.2016.08.075.
5
Purinergic signalling in the musculoskeletal system.嘌呤能信号在肌肉骨骼系统中的作用。
Purinergic Signal. 2013 Dec;9(4):541-72. doi: 10.1007/s11302-013-9381-4. Epub 2013 Aug 14.
6
Identification of ATP-binding regions in the RyR1 Ca²⁺ release channel.鉴定 RyR1 钙释放通道中的 ATP 结合区域。
PLoS One. 2012;7(11):e48725. doi: 10.1371/journal.pone.0048725. Epub 2012 Nov 7.
Cell Calcium. 2004 May;35(5):427-31. doi: 10.1016/j.ceca.2003.10.006.
4
Altered inhibition of the rat skeletal ryanodine receptor/calcium release channel by magnesium in the presence of ATP.在ATP存在的情况下,镁对大鼠骨骼肌兰尼碱受体/钙释放通道的抑制作用发生改变。
Pflugers Arch. 2001 Mar;441(6):729-38. doi: 10.1007/s004240000484.
5
Heterogeneity of Ca2+ gating of skeletal muscle and cardiac ryanodine receptors.骨骼肌和心肌兰尼碱受体Ca2+门控的异质性。
Biophys J. 1997 Jul;73(1):141-56. doi: 10.1016/S0006-3495(97)78055-X.
6
The sarcoplasmic reticulum Ca2+ channel/ryanodine receptor: modulation by endogenous effectors, drugs and disease states.肌浆网Ca2+通道/雷诺丁受体:受内源性效应物、药物及疾病状态的调节
Pharmacol Rev. 1997 Mar;49(1):1-51.
7
Structure and function of ryanodine receptors.兰尼碱受体的结构与功能。
Am J Physiol. 1994 Jun;266(6 Pt 1):C1485-504. doi: 10.1152/ajpcell.1994.266.6.C1485.
8
Ryanodine receptor/Ca2+ release channels and their regulation by endogenous effectors.兰尼碱受体/Ca2+释放通道及其受内源性效应物的调节
Annu Rev Physiol. 1994;56:485-508. doi: 10.1146/annurev.ph.56.030194.002413.
9
Adenine nucleotide stimulation of Ca2+-induced Ca2+ release in sarcoplasmic reticulum.腺嘌呤核苷酸对肌浆网中钙诱导的钙释放的刺激作用。
J Biol Chem. 1984 Feb 25;259(4):2365-74.
10
Analysis of phosphoryl transfer mechanism and catalytic centre geometries of transport ATPase by means of spin-labelled ATP.
Biochim Biophys Acta. 1980 Sep 2;601(1):34-46. doi: 10.1016/0005-2736(80)90511-8.